Treatment 2026
65th Edition
Author(s)Maxine A. Papadakis; Michael
W. Rabow; Kenneth R. McQuaid; Paul L.
Nadler; Erika Leemann Price
TEST BANK
1
Reference — Disease Prevention & Health Promotion —
Vaccination counseling in adults
Question Stem: A 58-year-old man with well-controlled type 2
diabetes presents for routine care. He asks which vaccines he
still needs. Which recommendation best prioritizes vaccinations
for this patient?
,A. Annual influenza vaccine; one lifetime dose of pneumococcal
vaccine (PPSV23); tetanus booster every 10 years.
B. Annual influenza vaccine; pneumococcal vaccination per
age/condition schedule (PCV13/PCV20 or PPSV23 as
recommended); Tdap once then Td every 10 years.
C. Influenza vaccine only if he travels; no pneumococcal vaccine
before age 65; Tdap only if wound occurs.
D. Live attenuated influenza vaccine intranasally is preferred for
adults with diabetes; give PPSV23 only at age 65.
Correct Answer: B
Rationales:
• B (correct): Adults with diabetes should receive annual
influenza vaccine, pneumococcal vaccination according to
current adult schedule (age and risk-based PCV/PPSV
sequencing), and a Tdap once as adult with subsequent Td
every 10 years—this aligns with standard adult
immunization priorities.
• A: PPSV23 is not always the only pneumococcal
recommendation; sequencing with conjugate vaccines or
PCV20 may apply depending on age/risk.
• C: Influenza vaccination is recommended annually for all
adults, not only travelers; pneumococcal decisions depend
on age and comorbidities.
• D: Live attenuated influenza vaccine is contraindicated in
many adults with chronic conditions; pneumococcal
vaccine timing depends on age and risk.
, Teaching Point: Annual influenza and appropriate
pneumococcal/Tdap scheduling are essential for adults
with diabetes.
Citation (simplified APA): Expert author (2025). Adult
immunization counseling — expert-authored item (not
directly from CMDT).
2
Reference — Disease Prevention & Health Promotion —
Smoking cessation interventions
Question Stem: A 65-year-old woman who smokes 1 pack/day
of cigarettes for 40 years wants to quit. Which combination
offers the best evidence-based strategy to maximize cessation
success?
A. Brief counseling alone at clinic visits.
B. Nicotine replacement therapy (NRT) patch plus clinician
counseling and follow-up.
C. Advice to "cold turkey" quit without pharmacotherapy.
D. Hypnotherapy alone without pharmacologic support.
Correct Answer: B
Rationales:
• B (correct): Combining pharmacotherapy (e.g., NRT) with
behavioral counseling and follow-up is more effective than
either alone for long-term cessation, particularly in heavy,
long-term smokers.
, • A: Brief counseling improves quit rates but is less effective
alone compared with combined therapy.
• C: Abrupt cessation without support has lower success
rates than supported pharmacologic + counseling
approaches.
• D: Hypnotherapy alone lacks consistent, high-quality
evidence compared to combined pharmacologic and
counseling strategies.
Teaching Point: Combine pharmacotherapy with
counseling and follow-up to optimize smoking cessation.
Citation (simplified APA): Expert author (2025). Smoking
cessation — expert-authored item (not directly from
CMDT).
3
Reference — Disease Prevention & Health Promotion — Cancer
screening (breast and colorectal)
Question Stem: A 52-year-old woman with no significant
medical history asks about breast and colorectal cancer
screening. Which plan best reflects risk-based, evidence-
oriented screening for average-risk adults?
A. Mammography every 2 years beginning at 50 and colorectal
screening starting at 45 with shared decision on modality.
B. Mammography not needed until age 60; colonoscopy only if
symptomatic.